Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis

CONTEXT: Denosumab is a potent antiresorptive agent that reduces fractures in postmenopausal women with osteoporosis. OBJECTIVE: Determine effects of up to 10 years of denosumab on bone histology, remodeling, and matrix mineralization characteristics. DESIGN AND SETTING: International, multicenter,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Endocrinol Metab
Auteurs principaux: Dempster, David W, Brown, Jacques P, Fahrleitner-Pammer, Astrid, Kendler, David, Rizzo, Sebastien, Valter, Ivo, Wagman, Rachel B, Yin, Xiang, Yue, Susan V, Boivin, Georges
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2018
Sujets:
Clinical Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037073/
https://ncbi.nlm.nih.gov/pubmed/29672714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2017-02669
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires